• 9/16/2018
    Dr. Yousuf Al Maslamani, Medical Director of Hamad General Hospital (HGH) and Director of the Qatar Center for Organ Transplantation at Hamad Medical Corporation (HMC), has been elected Vice President of the Middle East Society for Organ Transplantation (MESOT) for a two-year term (until 2020). Dr. Al Maslamani’s election to the Vice President post was announced during the Society’s board meeting held during the 16th Congress for the MESOT in Ankara, Turkey from 5 to 7 September, 2018.
    Her Excellency Dr. Hanan Mohamed Al Kuwari, Minister of Public Health, congratulated Dr. Al Maslamani on the appointment. She noted the importance of Qatar’s organ donation and transplantation program, adding that the success of Qatar’s organ donation program is something which is recognized internationally and which the country can be extremely proud of. 

    “Qatar’s organ donation and transplantation program has continued to develop at a steady pace to meet the country’s ever-increasing demand while also maintaining a high standard in terms of the quality of care provided to both donors and recipients. The program is world-leading and has been recognized internationally for its focus on fairness and equality, and specifically the humane and unbiased nature of the service and its single unified national waiting list. I am confident that Dr. Al Maslamani’s appointment and his work with this eminent group of organ transplantation experts will be instrumental in the continued evolution of organ donation and transplantation in this region,” said Her Excellency Dr. Al Kuwari. 

    Dr. Al Maslamani said he was honored to have been elected to the Vice President post. Founded over 30 years ago, MESOT is among the most important organ transplantation organizations in the region. 

    “MESOT’s membership includes a number of highly-respected internists and international surgeons who are recognized as leading experts in the field of organ transplantation. Over the years, MESOT has gained extensive expertise in the field of organ transplantation and this had led to significant improvements in the field and helped to contribute to the development of more comprehensive healthcare systems across the Middle East region,” said Dr. Al Maslamani.

    According to Dr. Al Maslamani, this year surgical teams at the Qatar Center for Organ Transplantation have successfully performed seven liver and 19 kidney transplant surgeries. Additionally, in recent years, 47 patients have received 12 livers and 35 kidneys from ethically approved living and deceased donors.

    “We hope to see more organ transplantation surgeries performed at HMC. In recent years there has been a steady increase in the number of registered organ donors in Qatar. Since the Qatar Organ Donor Registry was launched in 2012, around 300,000 donors, or 15 percent of the country’s adult population, have registered as organ donors,” Dr. Al Maslamani concluded.